# Evaluation of CSF-3 in Performing ECG

> **NCT05591157** · NA · COMPLETED · sponsor: **CardiacSense Ltd.** · enrollment: 47 (actual)

## Conditions studied

- Healthy
- ECG

## Interventions

- **DEVICE:** CSF-3 watch, designed to monitor a user's heart rate based on ECG (electrocardiogram) and PPG (Photoplethysmograph) readings

## Key facts

- **NCT ID:** NCT05591157
- **Lead sponsor:** CardiacSense Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-11-16
- **Primary completion:** 2023-02-01
- **Final completion:** 2023-02-01
- **Target enrollment:** 47 (ACTUAL)
- **Last updated:** 2023-02-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05591157

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05591157, "Evaluation of CSF-3 in Performing ECG". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05591157. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*